Tag Archives: $VRUS

No, not inhibited ($INHX)

Posted on November 5, 2011 by BioChef in Training

This why biotech is fun. Beginning yesterday and continuing through the weekend, many investors’ eyes will be focused on The Liver Meeting, being held in San Francisco, with the latest advances in liver disease being shared and discussed. The first … Continue reading →

Posted in Research, Update | Tagged , , , , , , , , , , | Leave a comment

$INHX, inhibited?

Posted on September 1, 2011 by BioChef in Training

So, what do you do if you want to get some exposure in the hot HCV space? A space where competition is steep and filled with big-time players such as Roche, JNJ (Tibotec), Bristol-Myers, Merck, Boehringer, and even Pharmasset at … Continue reading →

Posted in Research | Tagged , , , , , , , , , , , , , | 2 Comments

No, I didn’t. Yes, $IDIX.

Posted on August 29, 2011 by BioChef in Training

A little late to the story, but what a ride for $IDIX over the course of the year. Source: Yahoo! Finance, 08-29-11 About this time last year, $IDIX was a $437 MM market cap company (c.73M shares outstanding x $5.99/share, … Continue reading →

Posted in Research | Tagged , , , , , , , , , , | 1 Comment